1-BOC-4-(3-IODO-2-PYRIDYL)PIPERAZINE
![]() |
- $110 - $805.27
- Product name: 1-BOC-4-(3-IODO-2-PYRIDYL)PIPERAZINE
- CAS: 902837-43-8
- MF: C14H20IN3O2
- MW: 389.23
- EINECS:
- MDL Number:MFCD07781155
- Synonyms:1-BOC-4-(3-IODO-2-PYRIDYL)PIPERAZINE;1-Piperazinecarboxylic acid, 4-(3-iodo-2-pyridinyl)-, 1,1-dimethylethyl ester
3 prices
Selected condition:
Brand
- A1 Biochem Labs
- American Custom Chemicals Corporation
- TRC
Package
- 500mg
- 1G
- 5G
- ManufacturerA1 Biochem Labs
- Product number6597055
- Product descriptiontert-Butyl4-(3-iodopyridin-2-yl)piperazine-1-carboxylate 95%
- Packaging5G
- Price$800
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0004904
- Product description4-(3-IODOPYRIDIN-2-YL)PIPERAZINE, N1-BOC PROTECTED 95.00%
- Packaging1G
- Price$805.27
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberT135740
- Product descriptiontert-Butyl4-(3-Iodopyridin-2-yl)piperazine-1-carboxylate
- Packaging500mg
- Price$110
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
A1 Biochem Labs | 6597055 | tert-Butyl4-(3-iodopyridin-2-yl)piperazine-1-carboxylate 95% | 5G | $800 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | HCH0004904 | 4-(3-IODOPYRIDIN-2-YL)PIPERAZINE, N1-BOC PROTECTED 95.00% | 1G | $805.27 | 2021-12-16 | Buy |
TRC | T135740 | tert-Butyl4-(3-Iodopyridin-2-yl)piperazine-1-carboxylate | 500mg | $110 | 2021-12-16 | Buy |
Properties
Boiling point :444.3±45.0 °C(Predicted)
Density :1.524±0.06 g/cm3(Predicted)
pka :6.40±0.29(Predicted)
Sensitive :Light Sensitive
Density :1.524±0.06 g/cm3(Predicted)
pka :6.40±0.29(Predicted)
Sensitive :Light Sensitive
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | |||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|